Literature DB >> 8824754

Humeral epicondylitis among gas- and waterworks employees.

B R Ritz1.   

Abstract

OBJECTIVES: In this cross-sectional study 290 male employees of the public gas- and waterworks of Hamburg, Germany, were examined for symptoms of epicondylitis. Forty-one workers were diagnosed with symptoms of lateral or medial epicondylitis. The effect of employment in different job categories on the prevalence of epicondylitis was explored.
METHODS: The diagnosis of epicondylitis was based on the study's own criteria and compared with criteria used in former studies. Jobs were categorized into high, moderate, and no exposure groups according to tasks regarded as strenuous for the elbow. The data were analyzed with the help of multivariate logistic regression.
RESULTS: With the study's diagnostic criteria, the prevalence odds ratio (OR) for 10 years of high exposure to elbow straining work was 1.7 [95% confidence interval (95% CI) 1.04-2.68] for currently held jobs and 2.16 (95% CI 1.08-4.32) for formerly held jobs. For workers regarded as moderately exposed in current jobs the odds ratio for 10 years was 1.4 (95% CI 1.00-1.93). Very similar results were obtained for current exposure when stricter diagnostic criteria were employed.
CONCLUSIONS: The results suggest a cumulative exposure effect with length of employment. Workers with high exposure in former jobs compared with employees with high exposure in their current job exhibited more residual or slight epicondylitis symptoms upon examination.

Entities:  

Mesh:

Year:  1995        PMID: 8824754     DOI: 10.5271/sjweh.64

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  15 in total

1.  Medial epicondylitis in occupational settings: prevalence, incidence and associated risk factors.

Authors:  A Descatha; A Leclerc; J F Chastang; Y Roquelaure
Journal:  J Occup Environ Med       Date:  2003-09       Impact factor: 2.162

Review 2.  Prolotherapy in primary care practice.

Authors:  David Rabago; Andrew Slattengren; Aleksandra Zgierska
Journal:  Prim Care       Date:  2010-03       Impact factor: 2.907

3.  Symptoms of hand-arm vibration syndrome in gas distribution operatives.

Authors:  K Palmer; G Crane; H Inskip
Journal:  Occup Environ Med       Date:  1998-10       Impact factor: 4.402

4.  Job experience, work load, and risk of musculoskeletal disorders.

Authors:  M Häkkänen; E Viikari-Juntura; R Martikainen
Journal:  Occup Environ Med       Date:  2001-02       Impact factor: 4.402

Review 5.  Prolotherapy for Osteoarthritis and Tendinopathy: a Descriptive Review.

Authors:  David Rabago; Bobby Nourani
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

6.  Physical and psychosocial risk factors for lateral epicondylitis: a population based case-referent study.

Authors:  J P Haahr; J H Andersen
Journal:  Occup Environ Med       Date:  2003-05       Impact factor: 4.402

7.  The efficacy of prolotherapy for lateral epicondylosis: a pilot study.

Authors:  Michael Scarpone; David P Rabago; Aleksandra Zgierska; Gennie Arbogast; Edward Snell
Journal:  Clin J Sport Med       Date:  2008-05       Impact factor: 3.638

Review 8.  A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma.

Authors:  D Rabago; T M Best; A E Zgierska; E Zeisig; M Ryan; D Crane
Journal:  Br J Sports Med       Date:  2008-11-21       Impact factor: 13.800

Review 9.  Optimising case definitions of upper limb disorder for aetiological research and prevention: a review.

Authors:  Keith T Palmer; E Clare Harris; Cathy Linaker; Cyrus Cooper; David Coggon
Journal:  Occup Environ Med       Date:  2011-10-17       Impact factor: 4.402

10.  Disease Burden of Medial Epicondylitis in the USA Is Increasing: An Analysis of 19,856 Patients From 2007 to 2014.

Authors:  Anthony J Wiggins; Jourdan M Cancienne; Christopher L Camp; Ryan M Degen; David W Altchek; Joshua S Dines; Brian C Werner
Journal:  HSS J       Date:  2018-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.